Literature DB >> 9212306

Vascular homeostasis, adhesion molecules, and macrovascular disease in non-insulin-dependent diabetes mellitus.

A M Carter1, P J Grant.   

Abstract

Diabetes mellitus is characterized by fasting hyperglycaemia and the development of chronic vascular complications. While microvascular disease has been strongly related to glycaemic control, the major cause of mortality in diabetes is due to macrovascular disease affecting the cardiac and cerebrovascular circulations, which appear to have a more complex pathogenesis. Diabetes is associated with a 3-5-fold increase in death from myocardial infarction and similar figures pertain to stroke. The processes involved in atherothrombotic disease are complex and include variation in lipid metabolism, vascular responses, cell/cell interactions, and in the fluid and cellular phases of coagulation and fibrinolysis. The complex interactions between all of these processes are crucially altered by the metabolic milieu that characterizes diabetes mellitus, tipping the delicate balance towards atheroma formation, platelet aggregation and thrombus formation. This article will review these mechanisms and the effects of diabetes in the pathogenesis of vascular disease.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9212306     DOI: 10.1002/(SICI)1096-9136(199706)14:6<423::AID-DIA421>3.0.CO;2-F

Source DB:  PubMed          Journal:  Diabet Med        ISSN: 0742-3071            Impact factor:   4.359


  2 in total

1.  Effects of TNF-alpha antagonism on E-selectin in obese subjects with metabolic dysregulation.

Authors:  Markella V Zanni; Takara L Stanley; Hideo Makimura; Cindy Y Chen; Steven K Grinspoon
Journal:  Clin Endocrinol (Oxf)       Date:  2010-07       Impact factor: 3.478

2.  Serum E-selectin concentration is associated with risk of metabolic syndrome in females.

Authors:  Chien-Hsing Lee; Feng-Chih Kuo; Wen-Hao Tang; Chieh-Hua Lu; Sheng-Chiang Su; Jhih-Syuan Liu; Chang-Hsun Hsieh; Yi-Jen Hung; Fu-Huang Lin
Journal:  PLoS One       Date:  2019-09-24       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.